 Acorda Therapeutics, Inc. NASDAQ:ACOR Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen - CEO Mike Gesser - CFO Operator Ladies and gentlemen, welcome to Acorda Therapeutics Second Quarter 2022 Financial and Business Update. Operator Instructions Please be advised that this call is being recorded at the companys request. 